Change in Senior Management Personnel

30th July, 2026 The Dy. General Manager (Listing Dept.) The Manager – Listing Dept., BSE Limited, National Stock Exchange of India Ltd., Corporate Relationship Dept., Exchange Plaza, 5th Floor, 1st Floor, New Trading Ring, Plot No. C/1, G. Block, P. J. Towers, Dalal Street, Fort, Bandra - Kurla Complex, Bandra (E), Mumbai - 400 001 Mumbai – 400 051 (BSE Scrip Code: 500420) (NSE Scrip Code: TORNTPHARM) Dear Sir, Sub.: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Change in Senior Management Personnel (SMP) Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), we would like to inform you that Hasmukh Patel, Sushil Jaiswal and Sunil Nadkarni designated as SMPs of the Company has ceased to be part of Senior Management w.e.f. 30th July, 2026 due to change in reporting structure. The details as required under Regulation 30 of Listing Regulations read with SEBI Master Circular no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January, 2026 is enclosed herewith as Annexure-A. Thanking you, Yours Sincerely, For TORRENT PHARMACEUTICALS LIMITED CHINTAN M. TRIVEDI COMPANY SECRETARY Encl: A/a Email – investorservices@torrentpharma.com Annexure – A Particulars Details Name Hasmukh Patel Sushil Jaiswal Sunil Nadkarni Reason for change ceased to be part of ceased to be part of ceased to be part of SMP viz. appointment, SMP due to change SMP due to change in due to change in reappointment, in reporting reporting structure reporting structure resignation, removal, structure death or otherwise Date of appointment / 30th July, 2026 30th July, 2026 30th July, 2026 reappointment / (effective from (effective from close (effective from close of cessation (as close of business of business business applicable) & term of hours) hours) hours) appointment/re- appointment Brief Profile (In case Not applicable Not applicable Not applicable of appointment) Disclosure of Not applicable Not applicable Not applicable relationships between directors (in case of appointment of Director) Email – investorservices@torrentpharma.com